Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors
- 1 December 1994
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 35 (3) , 246-248
- https://doi.org/10.1007/s002800050226
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: